A detailed history of Artal Group S.A. transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Artal Group S.A. holds 2,525,998 shares of MORF stock, worth $144 Million. This represents 5.45% of its overall portfolio holdings.

Number of Shares
2,525,998
Previous 2,213,188 14.13%
Holding current value
$144 Million
Previous $77.9 Million 10.47%
% of portfolio
5.45%
Previous 4.2%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$26.12 - $34.07 $8.17 Million - $10.7 Million
312,810 Added 14.13%
2,525,998 $86.1 Million
Q1 2024

May 13, 2024

BUY
$26.64 - $40.31 $2 Million - $3.02 Million
75,000 Added 3.51%
2,213,188 $77.9 Million
Q3 2023

Nov 13, 2023

SELL
$21.33 - $59.42 $38,543 - $107,371
-1,807 Reduced 0.08%
2,138,188 $49 Million
Q2 2023

Aug 11, 2023

BUY
$34.33 - $62.11 $11.2 Million - $20.3 Million
326,046 Added 17.97%
2,139,995 $123 Million
Q1 2023

May 12, 2023

SELL
$26.01 - $48.69 $8.74 Million - $16.4 Million
-336,051 Reduced 15.63%
1,813,949 $68.3 Million
Q3 2022

Nov 14, 2022

BUY
$22.23 - $33.37 $11.1 Million - $16.7 Million
500,000 Added 30.3%
2,150,000 $60.8 Million
Q1 2022

May 12, 2022

BUY
$36.25 - $52.02 $2.35 Million - $3.38 Million
64,951 Added 4.1%
1,650,000 $66.2 Million
Q3 2021

Nov 12, 2021

SELL
$53.61 - $67.5 $12.6 Million - $15.8 Million
-234,137 Reduced 12.87%
1,585,049 $89.8 Million
Q1 2021

May 14, 2021

BUY
$29.77 - $84.85 $4.99 Million - $14.2 Million
167,500 Added 10.14%
1,819,186 $115 Million
Q3 2020

Nov 13, 2020

SELL
$22.51 - $30.11 $393,925 - $526,925
-17,500 Reduced 1.05%
1,651,686 $45.2 Million
Q2 2020

Aug 14, 2020

SELL
$12.65 - $29.57 $1.9 Million - $4.44 Million
-150,000 Reduced 8.25%
1,669,186 $45.2 Million
Q3 2019

Nov 14, 2019

BUY
$17.46 - $29.05 $23 Million - $38.3 Million
1,319,186 Added 263.84%
1,819,186 $32.9 Million
Q2 2019

Aug 09, 2019

BUY
$18.0 - $19.82 $9 Million - $9.91 Million
500,000 New
500,000 $9.91 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.